Mirae Asset Global ETFs Holdings
ATNM icon

Mirae Asset Global ETFs Holdings’s Actinium Pharmaceuticals ATNM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,853
Closed -$28.7K – 3021
2025
Q1 		$28.7K Buy
17,853
+780
+5% +$990 ﹤0.01% 2935
2024
Q4 		$21.5K Buy
17,073
+760
+5% +$1.18K ﹤0.01% 3000
2024
Q3 		$30.7K Buy
16,313
+1,670
+11% +$6.6K ﹤0.01% 2988
2024
Q2 		$108K Buy
+14,643
New +$121K ﹤0.01% 2530

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ATNM Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 17,853 shares — an estimated $28.7K sold.

Mirae Asset Global ETFs Holdings first reported a position in ATNM in Q2 2024 and held it in 4 quarters. The position peaked at $108K in Q2 2024. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 17,853 Actinium Pharmaceuticals shares in Q2 2025, an estimated $28.7K.
  • Mirae Asset Global ETFs Holdings first reported a position in Actinium Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Actinium Pharmaceuticals position peaked at $108K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.